Elliot Norry Net Worth & Insider Trades

Elliot Norry - Chief Medical Officer, Adaptimmune Therapeutics Plc

As of January 18, 2022

What is Elliot Norry's Net Worth?

The current estimated net worth of Adaptimmune Therapeutics Plc's Chief Medical Officer, Elliot Norry, is estimated to be about $55.03K . Elliot Norry owns about 3,529 units of Adaptimmune Therapeutics Plc common stock. In the last 2 years at Adaptimmune Therapeutics Plc, Elliot Norry has sold an estimated value of $52.98K worth.

What is Elliot Norry's Past Insider Trading?

Elliot Norry's largest sale order was 4,624 units , worth over $16.44K on January 13, 2022. In total, Elliot Norry has made about 10 transactions over 2 years of their time at Adaptimmune Therapeutics Plc. Elliot Norry usually trades in January, with the busiest year in 2021 and 2022. The most recent transaction was a sale order of 2,121 units , worth over $6.77K on January 18, 2022.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Elliot Norry's' Mailing Address?

  • Mailing address is 351 Rouse Boulevard Philadelphia PA 19112 PA

Adaptimmune Therapeutics Plc Executive Compensation

Name
Year
Salary
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Adrian Rawcliffe 2020 $574,000 $1,715,346 $378,840 $33,416 $2,701,602
Adrian Rawcliffe 2019 $500,481 $1,427,399 $177,251 $49,912 $2,155,042
Adrian Rawcliffe 2018 $457,011 $730,791 $174,807 $54,775 $1,417,384
Gavin Wood 2020 $337,065 $990,268 $166,847 $73,731 $1,567,911
Helen Tayton-Martin 2020 $454,940 $857,661 $225,195 $23,531 $1,561,327
Helen Tayton-Martin 2019 $435,949 $766,900 $137,324 $30,491 $1,370,664
Helen Tayton-Martin 2018 $408,308 $730,791 $156,178 $22,007 $1,317,284
William Bertrand 2020 $443,456 $857,661 $219,511 $30,485 $1,551,113
William Bertrand 2019 $432,640 $766,900 $136,282 $35,358 $1,371,180
William Bertrand 2018 $416,000 $685,114 $159,120 $35,070 $1,295,304
John Lunger 2020 $400,000 $857,661 $198,000 $31,802 $1,487,463
John Lunger 2019 $366,867 $435,546 $94,542 $35,655 $932,610
John Lunger 2018 $316,958 $602,909 $92,948 $35,07 $1,047,885
Michael Garone 2020 $217,000 - - - $217,000
Michael Garone 2019 $206,500 - - - $206,500
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1621227/000110465921047833/tm212433-2_def14a.htm

What are Adaptimmune Therapeutics Plc's Past Insider Trades?

Adaptimmune Therapeutics Plc's most recent insider trade came on September 1, 2022 by Adrian Rawcliffe who sold 2,536 units worth $4.99K . In the last 6 years, insiders at Adaptimmune Therapeutics Plc have sold an estimated value of $40.15M and bought an estimated value of $526.78M worth of shares. Insider trading is most common in January, with the busiest year in 2018. The most active traders at the company are Adrian Rawcliffe, Chief Executive Officer,  John Lunger, Chief Patient Supply Officer,  and William Charles Bertrand, Chief Operating Officer .

Adaptimmune Therapeutics PLC Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1